TCT · San Diego · 2026-10-31 – 2026-11-03

TCT 2026

0 di 28 studi Late-Breaking con risultato

I risultati sono sotto embargo fino a ciascuna presentazione e compaiono qui appena vengono resi noti.

sab 31 ott

10:45–12:13 (America/Los_Angeles) · Main Arena · Hall H

10:45P4Studio clinico · Carlos ColletCoronary CT Angiography-Guided vs. IVUS-Guided PCI: The Randomized P4 TrialPresentato — risultato in arrivo
11:07TRANSFORM IIStudio clinico · Bernardo CorteseSirolimus Coated Balloons vs. Drug-eluting Stents in Native Coronary Vessels: The TRANSFORM II Randomized TrialPresentato — risultato in arrivo
11:29HD-PCIStudio clinico · Sanjit S. JollyA Randomized Trial of Higher vs. Lower Dose Heparin for PCI: The HD-PCI TrialPresentato — risultato in arrivo
11:51REMEDY-PILOTStudio clinico · Kevin ChengCoronary Sinus Reducer for Refractory Angina in ANOCA: A Randomized Double-Blind Sham-Controlled Trial (REMEDY-PILOT)Presentato — risultato in arrivo

14:15–15:45 (America/Los_Angeles) · Main Arena · Hall H

14:15VERITASStudio clinico · Dhanunjaya LakkireddyOne-Year Outcomes with the Amulet 360 Device for Left Atrial Appendage Closure: The VERITAS Amulet 360 StudyPresentato — risultato in arrivo
14:33Community TR cohortStudio osservazionale · Rebecca T. HahnCharacteristics and Clinical Outcomes of Tricuspid Regurgitation in the Community: Insights from a Real-World Cohort of 180,977 Men and WomenPresentato — risultato in arrivo
14:51TRAVEL IIIStudio clinico · Junbo GeTranscatheter Tricuspid Valve Replacement with the LuX-Valve Plus System vs. Medical Therapy for Severe TR: The Randomized TRAVEL III TrialPresentato — risultato in arrivo
15:09TRIC-I-HF subgroupsStudio osservazionale · Jörg HausleiterTranscatheter Tricuspid Valve Intervention in Heart Failure: Key Subgroup Results from the TRIC-I-HF-DZHK24 TrialPresentato — risultato in arrivo
15:27EARLY TAVR economicsStudio osservazionale · Neel ButalaEconomic Outcomes and Cost-Effectiveness of TAVR for Asymptomatic Severe Aortic Stenosis: Results from the EARLY TAVR TrialPresentato — risultato in arrivo

09:40–11:10 (America/Los_Angeles) · Main Arena · Hall H

09:40PROGRESSStudio clinico · Philippe GenereuxTAVR or Clinical Surveillance for Moderate Aortic Stenosis: Primary Results of the PROGRESS Randomized TrialPresentato — risultato in arrivo
10:04GBD degenerative mitral valve diseaseStudio osservazionale · Juan F. GranadaGlobal Burden and Outcomes of Degenerative Mitral Valve Disease: A 30-Year Analysis of the Global Burden of Disease StudyPresentato — risultato in arrivo
10:25CLASP II TRStudio clinico · Suzanne V. Arnold, Charles J. DavidsonTranscatheter Tricuspid Valve Repair with the PASCAL System vs. Medical Therapy for Severe, Symptomatic Tricuspid Regurgitation: Clinical and Health Status Outcomes from the CLASP II TR Randomized TrialPresentato — risultato in arrivo
10:49SIMPLAAFYStudio clinico · Saibal KarAntithrombotic Monotherapy After Left Atrial Appendage Occlusion: Primary Results of the SIMPLAAFY Randomized TrialPresentato — risultato in arrivo

14:15–15:45 (America/Los_Angeles) · Main Arena · Hall H

14:15PeriSorbStudio clinico · Yuan CheOne-Year Outcomes of the PeriSorb Bioresorbable Vascular Scaffold vs. Drug-Coated Balloon for Superficial Femoral Artery Disease: A Multicenter Randomized TrialPresentato — risultato in arrivo
14:33SIRONAStudio clinico · Ulf TeichgräberThree-Year Outcomes of Sirolimus vs. Paclitaxel-Coated Balloons for Femoropopliteal Artery Disease: The Randomized SIRONA TrialPresentato — risultato in arrivo
14:51AIR STEMI non-culprit severityStudio osservazionale · Simone BiscagliaImpact of Non-Culprit Lesion Severity on the Utility of Functional Coronary Angiography in Patients with STEMI and Multivessel Disease: The AIR STEMI Randomized TrialPresentato — risultato in arrivo
15:09LIPSIA-STRATEGYStudio clinico · Nicolas MajunkeAngiography-Derived FFR Versus vs. Wire-Based FFR to Guide Coronary Revascularization: The LIPSIA-STRATEGY TrialPresentazione lun, 15:09
15:27Nicorandil no-reflow trialStudio clinico · Takashi MuramatsuIntracoronary Delivery of Nicorandil for Prevention of No-Reflow in Patients Undergoing Primary PCI for STEMI: A Multicenter Randomized TrialPresentazione lun, 15:27

10:45–12:15 (America/Los_Angeles) · Main Arena · Hall H

10:45PIONEER IVStudio clinico · Patrick W. SerruysAngiography-Derived FFR vs. Usual Care for Lesion Selection and Optimization in All-Comers PCI: Final Results of the PIONEER IV Randomized TrialPresentazione mar, 10:45
11:03EPIC17-VERONICAStudio clinico · Iñigo LozanoPlatelet Function Testing to Guide P2Y12 Inhibitor De-Escalation After ACS: The EPIC17-VERONICA Randomized TrialPresentazione mar, 11:03
11:21SPYRAL AFFIRMStudio clinico · David E. KandzariSafety and Effectiveness of Radiofrequency Renal Denervation in the United States: Primary Results of the SPYRAL AFFIRM Post-Approval StudyPresentazione mar, 11:21
11:39SINGLE-CLOSUREStudio clinico · Jun JiangSingle vs. Double ProGlide Devices for Access Site Closure After Transfemoral TAVR: The SINGLE-CLOSURE TrialPresentazione mar, 11:39
11:57IRIS-MAINStudio osservazionale · Duk-Woo ParkLong-Term Survival after Coronary Revascularization for Unprotected Left Main Disease (the IRIS-MAIN Registry): A Prospective, Multicenter, Multinational Cohort StudyPresentazione mar, 11:57

12:20–13:50 (America/Los_Angeles) · Main Arena · Hall H

12:20ENCIRCLEStudio clinico · John G. WebbPercutaneous Transcatheter Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation: 2-Year Outcomes from the ENCIRCLE TrialPresentazione mar, 12:20
12:38PROTEMBOStudio clinico · Susheel K. KodaliThe ProtEmbo® Cerebral Protection System During TAVR: Final Results of the Randomized PROTEMBO IDE TrialPresentazione mar, 12:38
12:56JENA-VADStudio clinico · Torsten P. VahlTranscatheter Aortic Valve Replacement with the JenaValve Trilogy System for Aortic Regurgitation in Patients with a Left Ventricular Assist Device: The JENA-VAD StudyPresentazione mar, 12:56
13:14DUOTAPStudio clinico · Maximilian AutherithRoutine Post-Dilation vs. Conventional Deployment for Balloon-Expandable TAVR: The Randomized DUOTAP TrialPresentazione mar, 13:14
13:32TAVR vs SAVR for aortic regurgitationStudio clinico · YAOFU ZHENGTranscatheter vs. Surgical AVR for Symptomatic, Severe Aortic Regurgitation: One-Year Outcomes from a Multicenter Randomized TrialPresentazione mar, 13:32